Skip to main content
Login
Contact
Subscribe
Search form
Search
The Daily Press
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
St. Mary's Chamber
Elk County Sheriff
St. Mary's Area School District
Elk County Catholic School System
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Strongbridge Bio Ord
(NQ:
SBBP
)
3.410
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
5:26 PM EDT, Jun 2, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
3.410
Bid (Size)
3.410 (1)
Ask (Size)
3.700 (3)
Prev. Close
3.410
Today's Range
3.410 - 3.410
52wk Range
1.430 - 3.890
Shares Outstanding
35,335,026
Dividend Yield
N/A
Performance
YTD
+70.50%
+70.50%
1 Month
+27.72%
+27.72%
3 Month
+26.30%
+26.30%
6 Month
+86.34%
+86.34%
1 Year
+17.99%
+17.99%
Top News
More News
Strongbridge Biopharma plc to Present at the Jefferies Virtual Healthcare Conference
June 01, 2020
from
GlobeNewswire News Releases
Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
May 20, 2020
from
GlobeNewswire News Releases
More News
Read More
Strongbridge Biopharma plc to Present at Upcoming 2020 Solebury Trout Virtual Global Healthcare Conference Series
May 18, 2020
from
GlobeNewswire News Releases
Strongbridge Biopharma plc Announces Completion of Enrollment of Phase 3 LOGICS Study for RECORLEV® (levoketoconazole) for Endogenous Cushing’s Syndrome
May 11, 2020
from
GlobeNewswire News Releases
Strongbridge Biopharma plc Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 06, 2020
from
GlobeNewswire News Releases
Strongbridge Biopharma plc to Host First Quarter 2020 Financial Results Conference Call on May 6, 2020
April 20, 2020
from
GlobeNewswire News Releases
Strongbridge Biopharma plc to Present at the Cowen and Company 40th Annual Healthcare Conference
February 27, 2020
from
GlobeNewswire News Releases
Analysts Anticipate 17% Upside For The Holdings of UWM
May 19, 2020
category
ETFs
from
ETF Channel
Recap: Strongbridge Biopharma Q1 Earnings
May 06, 2020
category
SBBP
,
Market News
,
News
, and 2 more.
from
Benzinga
Analysts Expect IWN Will Reach $118
April 15, 2020
category
ETFs
from
ETF Channel
Look Under The Hood: VTWV Has 21% Upside
February 28, 2020
category
ETFs
from
ETF Channel
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
